Literature DB >> 29476775

Whole-Exome Sequencing of Acquired Nevi Identifies Mechanisms for Development and Maintenance of Benign Neoplasms.

Mitchell S Stark1, Jean-Marie Tan2, Lisa Tom2, Kasturee Jagirdar2, Duncan Lambie3, Helmut Schaider4, H Peter Soyer4, Richard A Sturm2.   

Abstract

The melanoma transformation rate of an individual nevus is very low despite the detection of oncogenic BRAF or NRAS mutations in 100% of nevi. Acquired melanocytic nevi do, however, mimic melanoma, and approximately 30% of all melanomas arise within pre-existing nevi. Using whole-exome sequencing of 30 matched nevi, adjacent normal skin, and saliva we sought to identify the underlying genetic mechanisms for nevus development. All nevi were clinically, dermoscopically, and histopathologically documented. In addition to identifying somatic mutations, we found mutational signatures relating to UVR mirroring those found in cutaneous melanoma. In nevi we frequently observed the presence of the UVR mutation signature compared with adjacent normal skin (97% vs. 10%, respectively). Copy number aberration analysis showed that for nevi with copy number loss of tumor suppressor genes, this loss was balanced by loss of potent oncogenes. Moreover, reticular and nonspecific patterned nevi showed an increased (P < 0.0001) number of copy number aberrations compared with globular nevi. The mutation signature data generated in this study confirms that UVR strongly contributes to nevogenesis. Copy number changes reflect at a genomic level the dermoscopic differences of acquired melanocytic nevi. Finally, we propose that the balanced loss of tumor suppressor genes and oncogenes is a protective mechanism of acquired melanocytic nevi.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29476775     DOI: 10.1016/j.jid.2018.02.012

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Massively parallel sequencing analysis of benign melanocytic naevi.

Authors:  John R Lozada; Felipe C Geyer; Pier Selenica; David Brown; Barbara Alemar; Taha Merghoub; Michael F Berger; Klaus J Busam; Allan C Halpern; Britta Weigelt; Jorge S Reis-Filho; Travis J Hollmann
Journal:  Histopathology       Date:  2019-05-24       Impact factor: 5.087

2.  Differential Immunoexpression of BRAF/V600E, Senescence Markers, PTEN, and T-type Calcium Channels in Acquired Naevi According to their Histopathological and Dermoscopic Classification.

Authors:  Sara Moreno; Oscar Maiques; Carla Barcelo; Marta Romero; Maria Santacana; Ignacio Gómez; Dolors Cuevas; Ana Velasco; Alvar Vea; Anna Macia; Ramon Boix; Joan Valls; Sonia Gatius; Carles Canti; Xavier Matias-Guiu; Xavier Soria; Rosa M Marti
Journal:  Acta Derm Venereol       Date:  2021-11-24       Impact factor: 3.875

3.  The deacylase SIRT5 supports melanoma viability by influencing chromatin dynamics.

Authors:  William Giblin; Lauren Bringman-Rodenbarger; Angela H Guo; Surinder Kumar; Alexander C Monovich; Ahmed M Mostafa; Mary E Skinner; Michelle Azar; Ahmed Sa Mady; Carolina H Chung; Namrata Kadambi; Keith-Allen Melong; Ho-Joon Lee; Li Zhang; Peter Sajjakulnukit; Sophie Trefely; Erika L Varner; Sowmya Iyer; Min Wang; James S Wilmott; H Peter Soyer; Richard A Sturm; Antonia L Pritchard; Aleodor A Andea; Richard A Scolyer; Mitchell S Stark; David A Scott; Douglas R Fullen; Marcus W Bosenberg; Sriram Chandrasekaran; Zaneta Nikolovska-Coleska; Monique E Verhaegen; Nathaniel W Snyder; Miguel N Rivera; Andrei L Osterman; Costas A Lyssiotis; David B Lombard
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

4.  Genome-Scale DNA Methylation Analysis Identifies Repeat Element Alterations that Modulate the Genomic Stability of Melanocytic Nevi.

Authors:  Meghan E Muse; Drew T Bergman; Lucas A Salas; Lisa N Tom; Jean-Marie Tan; Antonia Laino; Duncan Lambie; Richard A Sturm; Helmut Schaider; H Peter Soyer; Brock C Christensen; Mitchell S Stark
Journal:  J Invest Dermatol       Date:  2021-12-03       Impact factor: 7.590

5.  'Mind your Moles' study: protocol of a prospective cohort study of melanocytic naevi.

Authors:  Uyen Koh; Monika Janda; Joanne F Aitken; David L Duffy; Scott Menzies; Richard A Sturm; Helmut Schaider; Brigid Betz-Stablein; Tarl Prow; H Peter Soyer; Adele C Green
Journal:  BMJ Open       Date:  2018-09-19       Impact factor: 2.692

Review 6.  Acral Melanocytic Neoplasms: A Comprehensive Review of Acral Nevus and Acral Melanoma in Asian Perspective.

Authors:  Sanghyun Park; Sook-Jung Yun
Journal:  Dermatopathology (Basel)       Date:  2022-08-19

7.  Genomic profiling of late-onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome.

Authors:  O Hasan Ali; A A Yurchenko; O Pavlova; A Sartori; D Bomze; R Higgins; S S Ring; F Hartmann; D Bühler; F R Fritzsche; W Jochum; A A Navarini; A Kim; L E French; E Dermitzakis; A M Christiano; D Hohl; D R Bickers; S I Nikolaev; L Flatz
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-23       Impact factor: 6.166

Review 8.  The Interplay between Nevi and Melanoma Predisposition Unravels Nevi-Related and Nevi-Resistant Familial Melanoma.

Authors:  Stefania Pellegrini; Lisa Elefanti; Luigi Dall'Olmo; Chiara Menin
Journal:  Genes (Basel)       Date:  2021-07-16       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.